Balchem Corporation BCPC
167.89
0.05
0.03%
as of 25 Sep
- Market cap
- $5.4B
- P/E
- 33.0×
Follow BCPC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
33.19 | 34.80 | 32.29 | 32.84 |
+8 more quarters Free account |
P/S ratio |
4.96 | 5.12 | 4.77 | 4.78 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
115.39 | 135.11 | 73.55 | 73.84 | |
P/B ratio |
4.14 | 4.21 | 3.94 | 3.73 | |
Price to Tangible BV |
11.57 | 12.17 | 12.05 | 10.76 | |
EV/Sales |
5.07 | 5.24 | 4.88 | 4.89 | |
EV/EBITDA |
20.42 | 21.20 | 19.86 | 19.88 | |
EV/Operating CF |
25.07 | 25.15 | 23.39 | 24.59 | |
EV/FCF |
(44.19) | (46.24) | (41.30) | (36.99) | |
Quick Ratio |
1.46 | 1.49 | 1.24 | 1.56 | |
Current Ratio |
2.66 | 2.55 | 2.07 | 2.72 | |
Net Debt/EBITDA |
1.58 | 1.75 | 1.76 | 1.69 | |
Debt/Assets |
10.43% | 11.34% | 11.09% | 10.65% | |
Debt/Equity |
0.14 | 0.15 | 0.15 | 0.14 | |
Asset Turnover |
0.65 | 0.64 | 0.64 | 0.62 | |
Operating CF/Net income |
1.05 | 0.99 | 1.72 | 1.63 | |
Capex/Depreciation |
(0.89) | (0.50) | (1.38) | (1.32) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1.60% | 2.17% | 1.92% | 1.68% | |
Selling, General and Administrative Expense of Revenue |
14.06% | 14.62% | 13.87% | 13.60% | |
Intangible Assets out of Total Assets |
0.50 | 0.50 | 0.50 | 0.51 | |
Share Based Compensation of Revenue |
2.08% | 1.98% | 1.43% | 1.74% | |
Graham Net Nets |
0.00 | 0.00 | (0.01) | 0.00 | |
Graham Number |
68.38 | 66.40 | 64.54 | 64.31 | |
Earnings Yield |
3.01% | 2.87% | 3.10% | 3.05% | |
Free Cash Flow Yield |
(2.31%) | (2.21%) | (2.48%) | (2.77%) | |
Revenue per Share |
8.90 | 8.48 | 8.17 | 8.29 | |
Operating CF per Share |
1.46 | 1.25 | 2.09 | 2.03 | |
Capex per Share |
(0.34) | (0.20) | (0.50) | (0.47) | |
Free Cash Flow per Share |
1.12 | 1.06 | 1.58 | 1.56 | |
Cash per Share |
1.98 | 2.28 | 2.31 | 2.02 | |
Shareholders Equity per Share |
40.82 | 40.24 | 38.97 | 40.23 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
40.82 | 40.24 | 38.97 | 40.23 | |
Free Cash Flow |
35.83 | 33.81 | 51.07 | 50.35 | |
Working Capital |
242.67 | 236.40 | 189.23 | 217.35 | |
Capital Expenditures |
(10.88) | (6.25) | (16.21) | (15.23) | |
Net Current Asset Value |
3.80 | (19.68) | (63.22) | (19.45) | |
EV/EBIT |
24.84 | 25.88 | 24.19 | 24.24 | |
Capex to Sales |
0.04 | 0.02 | 0.06 | 0.06 | |
Net Profit Margin |
15.71% | 14.88% | 14.88% | 15.06% | |
Price to Operating Income |
24.31 | 25.30 | 23.64 | 23.68 | |
| Other line items | |||||
Average Receivables |
142.48 | 142.34 | 131.63 | 126.04 | |
Average Payables |
69.16 | 68.35 | 57.59 | 46.72 | |
Average Inventory |
154.85 | 145.83 | 131.13 | 125.47 | |
Average Assets |
1,682.63 | 1,655.65 | 1,630.81 | 1,628.99 | |
Average Common Equity |
1,285.15 | 1,246.91 | 1,203.66 | 1,237.55 |
Columns are period end dates